LONDON, August 26, 2016 /PRNewswire/ --
Analysis and Forecasts for Jet Injector Technologies and Competing Technologies Including Novel Needle Technology, Inhaler Technology and Microneedle Technology With an Assessment of Leading Companies Including Antares, Zogenix and 3M
What can be expected from the Needle-Free Delivery Technologies Market? Which areas are going to grow at the fastest rates? This visiongain report shows you potential revenues to 2026, assessing data, trends, opportunities and prospects.
Our 183-page report provides 105 tables, charts, and graphs. Discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales across all the major regional and national Needle-Free Delivery Technology markets. You will see financial results, trends, opportunities, and revenue predictions. There is much opportunity in this fast moving market.
Forecasts from 2016-2026 and other analyses show you commercial prospects
Besides revenue forecasting to 2026, our new study provides you with recent results, growth rates, and market shares. Discover qualitative analyses (including SWOT analysis) and commercial developments.
See revenue forecasts for the leading regional and national markets
How will leading national and regional markets perform to 2026? Our study forecasts revenues in national markets, including:
• US
• EU5 (Germany, France, UK, Italy and Spain)
• Japan
• China
• India
• Rest of the World
Leading companies and potential for market growth
Visiongain forecasts overall revenue for the Needle-Free Delivery Technologies Market will reach $2,093.9m in 2020. We predict high revenue growth over the forecast period, which will driven by the strong demand for improved vaccine and drug delivery methods.
To see a report overview please email Sara Peerun on [email protected]
Our work analyses the key companies in the market. See visiongain's analysis of six leading companies, including:
• 3M
• Antares Pharma
• Beckton Dickinson and Company (BD)
• Bioject Medical Technologies
• PharmaJet
• Zogenix
A company profile gives you the following information where available:
• Discussion of a company's activities and outlook including regional and national revenue shares
• Historic revenue, analysis and discussion of company performance
• Analysis of major products/services currently available on the market
• Acquisitions and strategic partnerships
Discover capabilities, progress, and commercial prospects, helping you stay ahead.
What issues will affect the needle-free drug delivery industry?
Our new report discusses issues and events affecting the needle-free delivery technology market. You will find discussions, including qualitative analyses:
• Highly fragmented and competitive market with significant variations in different geographic regions
• Changing political and regulatory landscape changing the prospects of future products and reimbursement opportunities
• Future opportunities for needle-free delivery technologies
You will see discussions of technological, commercial, and economic matters, with emphasis on the competitive landscape and business outlooks.
How the Needle-Free Delivery Technology Market Forecast 2016-2026: Analysis and Forecasts for Jet Injector Technologies and Competing Technologies including Novel Needle Technology, Inhaler Technology and Microneedle Technology with an Assessment of Leading Companies including Antares, Zogenix and 3M report helps you
In summary, our 183-page report gives you the following knowledge:
• Revenue forecasts to 2026 for the Needle-Free Delivery Technology Market - discover the industry's prospects, finding promising places for investments and revenues
• Revenue forecasts to 2026 for two major submarkets - jet injectors and competing technologies (novel needle technology, inhaler technology and transdermal patch technology)
• Revenue forecasts to 2026 for two major regional markets - EU5 and Rest of the World
• Revenue forecasts to 2026 for the leading national markets - US, Germany, France, UK, Italy, Spain, Japan, China, India and Rest of the World
• Assessment of leading companies - analysis of services, business operations, products, pipelines, revenue (where available) and recent mergers & acquisition activity
• Discussion of what stimulates and restrains companies and the market
• Prospects for established firms and those seeking to enter the market
You will find quantitative and qualitative analyses with independent predictions. You will receive information that only our report contains, staying informed with this invaluable business intelligence.
Information found nowhere else
With our survey you are less likely to fall behind in knowledge or miss opportunities. See how you could benefit your research, analyses, and decisions. Also see how you can save time and receive recognition for commercial insight.
Visiongain's study is for everybody needing commercial analyses for the needle-free drug delivery market and leading companies. You will find data, trends and predictions. Please order our report now.
To see a report overview please email Sara Peerun on [email protected]
To request a report overview of this report please emails Sara Peerun at [email protected] or call Tel: +44 (0) 20 7336 6100
Or click on https://www.visiongain.com/Report/1716/Needle-Free-Delivery-Technology-Market-Forecast-2016-2026
Companies Mentioned in the Report
3M
Actavis
Activa Brand Products
AcuShot
Adamis
Aktiv-Dry
Alkermes
Alza
Anesiva
Antares Pharma
Aradigm
Astellas Pharma
AstraZeneca
BD
BeadTek
Berlex Labs
Bespak
bioCSL
Bioject Medical Technologies
Biomedics
Boehringer Ingelheim
Bristol-Myers Squibb and Somerset Pharmaceuticals
Cambridge Consultants
CareFusion Corporation
CEA-LETI
Corium International
CosMed
Crossject
CureVac
D'Antonio Consultants International
Debiotech
Durect
Echo Therapeutics
Elcam Medical
Eli Lilly & Co
Endo International
Ethical Holdings/Schering
Eurojet Medical
Ferndale
Georgia Institute of Technology
Giant Eagle
GlaxoSmithKline
Glide Pharmaceutical Technologies
Hangzhou Hema Medical Equipment
Haselmeir GmbH
Health-Mor Personal Care
Hirtenberger
Ichor
iHealthNet
Immunomic Therapeutics
ImmusanT
Injex Pharma
Inovio Pharmaceuticals
Invion
Janssen Pharmaceuticals
Key Pharmaceuticals
Kroger
LEO Pharma
LTS Lohmann Therapie-Systeme
MannKind
Mecaplast
Meda Pharmaceuticals
Medac Pharma
Medical International Technologies
Medi-Ject
MedImmune
Merck
Merck Serono
Micron Biomedical
Mylan
nanoBioSciences
NanoPass
Napp Pharmaceuticals
National Medical Products
Nektar Therapeutics
Nemaura
Nicobrand Limited
Novartis
Novo Nordisk
Novogyne Pharmaceuticals
NuPathe
Nycomed
Ortho-McNeil
Owen MumFord Inc
Par Pharmaceutical
Parke-Davis
Penjet Corporation
Pernix
Pfizer
PharmaJet
PKA SoftTouch Corp
Procter & Gamble
ProStrakan
Purdue Pharma
Radius Health
Rhenovia Pharma
Rite Aid
Roche
Sandoz
Sanofi
Searle Pharmaceuticals
Shire
SHL Group AB
Shwarz-Pharma
Société Nationale des Poudres et Explosifs
STADA Arzneimittel AG
Stat Medical Devices
Takeda
Teva
The Medical House
TheraJect
TheraTech
Transdermal Specialties
Trimeris
Trinity-Chiesi
UCB Pharma
University of California-San Francisco
Vaxxas
Vetter Pharma
Vyteris
Watson
West Pharmaceuticals
Westmount Pharmacy
Ypsomed AG
Zogenix
Zosano
Zydus Cadila
To see a report overview please email Sara Peerun on [email protected]
SOURCE Visiongain Ltd
Share this article